Horizontal Ridge Augmentation Using an rhBMP ‐2 Loaded Volume‐Stable Collagen Matrix Compared to Guided Bone Regeneration: A Preclinical In Vivo Study
Journal of Clinical Periodontology · 2026
DOI: 10.1111/jcpe.70161 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Clinical Periodontology, 2026. Verfasst von Jin-Young Park und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Research Institute for Periodontal Regeneration, Yonsei University College of Dentistry, Seoul, South Korea. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 2, Alveolar Ridge Augmentation, Collagen, Transforming Growth Factor beta. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Health & Welfare, Republic of Korea.
Abstract (Originalsprache)
Aim
To investigate whether incorporation of recombinant human bone morphogenetic protein‐2 (rhBMP‐2) into a volume‐stable collagen matrix (VCMX) enhances horizontal ridge augmentation compared with VCMX alone or guided bone regeneration (GBR).
Methods
Chronic horizontal ridge defects were created in five canines. Sites randomly received: (1) control, (2) VCMX, (3) VCMX with rhBMP‐2 or (4) GBR (deproteinised bovine bone mineral with a collagen membrane). After 8 weeks, outcomes were assessed by profilometry, micro‐computed tomography and histomorphometry.
Results
VCMX/rhBMP‐2 showed significantly greater new bone volume (181.50 ± 142.32 mm 3 ) than GBR (36.06 ± 25.86), VCMX (8.40 ± 6.15) and control (7.32 ± 4.03 mm 3 ) (all p < 0.05). Histometric new bone thickness was greater in VCMX/rhBMP‐2 than GBR at all levels (crestal: 2.31 ± 1.93 vs. 1.09 ± 0.41 mm; p = 0.038). Coronal contour gain was higher in VCMX/rhBMP‐2 than VCMX ( p = 0.007), with no difference versus GBR ( p = 0.654). At middle and apical levels, all augmentation groups exceeded control ( p ≤ 0.011).
Conclusions
RhBMP‐2 delivered via VCMX enhanced horizontal bone regeneration with augmented dimensions comparable to GBR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, Research Institute for Periodontal Regeneration, Yonsei University College of Dentistry, Seoul, South Korea.
- Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA.
- School of Dentistry, Universidad Catolica de Santiago de Guayaquil (UCSG), Guayaquil, Ecuador.
- Division of Periodontics, Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Quebec, Canada.
- Clinic of Reconstructive Dentistry, Center of Dental Medicine, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Jin-Young Park, Seung-Hyun Park, Lorenzo Tavelli, David T Wu, Daniel S Thoma, Ui-Won Jung, Jae-Kook Cha
Förderung
- National Research Foundation of Korea
- Ministry of Health & Welfare, Republic of Korea
Zitieren
APA
Park, J. Y., Song, G. S., Park, S. H., Tavelli, L., Wu, D. T., Thoma, D. S., Jung, R. E., Jung, U. W., & Cha, J. K. (2026). Horizontal Ridge Augmentation Using an rhBMP ‐2 Loaded Volume‐Stable Collagen Matrix Compared to Guided Bone Regeneration: A Preclinical In Vivo Study. Journal of Clinical Periodontology. https://doi.org/10.1111/jcpe.70161
Vancouver
Park JY, Song GS, Park SH, Tavelli L, Wu DT, Thoma DS, et al. Horizontal Ridge Augmentation Using an rhBMP ‐2 Loaded Volume‐Stable Collagen Matrix Compared to Guided Bone Regeneration: A Preclinical In Vivo Study. Journal of Clinical Periodontology. 2026. doi:10.1111/jcpe.70161
BibTeX
@article{Park2026,
author = {Park, Jin-Young and Song, Gi-Seo and Park, Seung-Hyun and Tavelli, Lorenzo and Wu, David T and Thoma, Daniel S and Jung, Ronald E and Jung, Ui-Won and Cha, Jae-Kook},
title = {Horizontal Ridge Augmentation Using an rhBMP ‐2 Loaded Volume‐Stable Collagen Matrix Compared to Guided Bone Regeneration: A Preclinical In Vivo Study},
journal = {Journal of Clinical Periodontology},
year = {2026},
doi = {10.1111/jcpe.70161}
}
EUVIMED